BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 35821600)

  • 21. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PARP1 Gene Polymorphisms and the Prognosis of Esophageal Cancer Patients from Cixian High-Incidence Region in Northern China.
    Zhou RM; Li Y; Wang N; Niu CX; Huang X; Cao SR; Huo XR
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2987-2992. PubMed ID: 33112558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.
    Yang PW; Hsieh MS; Huang YC; Hsieh CY; Chiang TH; Lee JM
    PLoS One; 2014; 9(6):e100326. PubMed ID: 24945674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel transduction of nutrient stress to Notch pathway by RasGRP3 promotes malignant aggressiveness in human esophageal squamous cell carcinoma.
    Hu G; Zhou Y; Zhu Y; Zhou L; Ling R; Wu D; Mi L; Wang X; Dai D; Mao C; Chen D
    Oncol Rep; 2017 Nov; 38(5):2975-2984. PubMed ID: 29048643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population.
    Zhu J; Wang M; He J; Zhu M; Wang JC; Jin L; Wang XF; Yang YJ; Xiang JQ; Wei Q
    J Cell Mol Med; 2016 Apr; 20(4):666-77. PubMed ID: 26828791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.
    Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M
    Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Cumulative Risk of Genetic Polymorphisms in Familial and Nonfamilial Esophageal Squamous Cell Carcinoma.
    Suo C; Qing T; Liu Z; Yang X; Yuan Z; Yang YJ; Fan M; Zhang T; Lu M; Jin L; Chen X; Ye W
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2014-2021. PubMed ID: 31562207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The notch pathway is activated in neoplastic progression in esophageal squamous cell carcinoma.
    Lubin DJ; Mick R; Shroff SG; Stashek K; Furth EE
    Hum Pathol; 2018 Feb; 72():66-70. PubMed ID: 29137934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression.
    Cui SJ; Li Y; Zhou RM; Liu L; Cao SR; Huang X; Huo XR; Wang N
    Environ Mol Mutagen; 2021 Apr; 62(4):273-283. PubMed ID: 33723872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.
    Ma WJ; Lv GD; Zheng ST; Huang CG; Liu Q; Wang X; Lin RY; Sheyhidin I; Lu XM
    World J Gastroenterol; 2010 Feb; 16(5):641-7. PubMed ID: 20128036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.
    Ariyoshi Y; Shiozaki A; Ichikawa D; Shimizu H; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
    Oncotarget; 2017 Jan; 8(2):2209-2223. PubMed ID: 27902974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.
    Takemoto A; Tanimoto K; Mori S; Inoue J; Fujiwara N; Noda T; Inazawa J
    Cancer Sci; 2021 Oct; 112(10):4377-4392. PubMed ID: 34263978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.
    Zhang R; Zhou F; Cheng L; Yu A; Zhu M; Wang M; Zhang Z; Xiang J; Wei Q
    Mol Carcinog; 2018 Nov; 57(11):1553-1565. PubMed ID: 30035334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Association and Meta-Analysis of Esophageal Squamous Cell Carcinoma Risk Associated with PLCE1 rs2274223, C20orf54 rs13042395 and RUNX1 rs2014300 Polymorphisms.
    Nariman-Saleh-Fam Z; Saadatian Z; Nariman-Saleh-Fam L; Ouladsahebmadarek E; Tavakkoly-Bazzaz J; Bastami M
    Pathol Oncol Res; 2020 Apr; 26(2):681-692. PubMed ID: 30666517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China.
    Shen FF; Yue WB; Zhou FY; Pan Y; Zhao XK; Jin Y; Song X; Li B; Han XN; Tang S; Li Y; Yuan G; Chen LS; Liu YL; Hu YL; Li XM; Ren JL; Wang LD
    PLoS One; 2014; 9(3):e90438. PubMed ID: 24595008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
    Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
    Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.